The CBO has found that the Democratic plan that would allow Medicare to negotiate prescription drug prices would save the country $287 billion.
Prescription Drug Reform Is A Win For The American People And The Deficit
The CBO scored the Senate Democratic plan to allow Medicare to negotiate prescription drug prices and found:
CBO estimates that enacting this legislation would result in a net decrease in the unified deficit totaling $287.6 billion over the 2022-2031 period. That decrease in the deficit would result from a decrease in direct spending of $249.2 billion and an increase in revenues of $38.4 billion.
Some of those budgetary effects are associated with programs that are classified as off-budget. The decrease in the on-budget deficit over that period would be $276.7 billion.
Mitch McConnell And Senate Republicans Oppose Lowering The Cost Of Prescription Drugs
McConnell and Senate Republicans don’t want people to pay less for their medicine, as they will force Democrats to pass the legislation through reconciliation instead of supporting it as a bipartisan bill.
The Odds Of Mitch McConnell Becoming Senate Majority Leader Again Are Dropping
Sen. McConnell is seeing his chances of becoming Senate majority leader again decline through a combination of a post-Roe changing electoral landscape, bad Republican candidates, and unpopular choices like refusing to support lowering prescription drug prices.
McConnell is giving Democrats another issue to run on this fall.
The Senate Republican refusal to support prescription drug reform has given Democrats a powerful example of how McConnell and Senate Republicans will put the American people last if put back into power.
- Trump And House GOP’s Promise To Not Cut Social Security Is Total Nonsense - Fri, Dec 20th, 2024
- Trump And Mike Johnson Agree To Apparently Cut Americans’ Healthcare To Pay For Tax Cuts For The Rich - Fri, Dec 20th, 2024
- Dozens Of Republicans Humiliate Trump/Musk By Voting Down CR - Thu, Dec 19th, 2024